Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P M Parker

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Journal of Pediatric Surgery|May 1, 1989
Intravenous digital subtraction angiography: its use in evaluating vascular injuries in childrenP M Parker, C D Vinocur, E Smergel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1995
Busulfan/cyclophosphamide as conditioning regimen for allogeneic bone marrow transplantation for myelodysplasiaM R O'Donnell, G D Long, P M Parker, et al.
Journal of Steroid Biochemistry|December 1, 1978
Dehydroisoandrosterone sulfate in peripheral blood of premenopausal, pregnant and postmenopausal women and menL Milewich, C Gomez-Sanchez, J D Madden, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1994
High-dose therapy followed by autologous peripheral-blood stem-cell transplantation for patients with Hodgkin's disease and non-Hodgkin's lymphoma using unprimed and granulocyte colony-stimulating factor-mobilized peripheral-blood stem cellsA Nademanee, I Sniecinski, G M Schmidt, et al.
Blood|March 1, 1995
High-dose chemotherapy with or without total body irradiation followed by autologous bone marrow and/or peripheral blood stem cell transplantation for patients with relapsed and refractory Hodgkin's disease: results in 85 patients with analysis of prognostic factorsA Nademanee, M R O'Donnell, D S Snyder, et al.
Blood|September 1, 1994
Fractionated total-body irradiation and high-dose etoposide as a preparatory regimen for bone marrow transplantation for 94 patients with chronic myelogenous leukemia in chronic phaseD S Snyder, R S Negrin, M R O'Donnell, et al.
Blood|August 1, 1987
Bone marrow transplantation for patients with Philadelphia chromosome-positive acute lymphoblastic leukemiaS J Forman, M R O'Donnell, A P Nademanee, et al.
Blood|October 15, 1991
Allogeneic bone marrow transplantation for high-risk acute lymphoblastic leukemia during first complete remissionN J Chao, S J Forman, G M Schmidt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1987
Bone marrow transplantation for myelodysplastic and myeloproliferative syndromesM R O'Donnell, A P Nademanee, D S Snyder, et al.
The New England Journal of Medicine|October 21, 1993
Cyclosporine, methotrexate, and prednisone compared with cyclosporine and prednisone for prophylaxis of acute graft-versus-host diseaseN J Chao, G M Schmidt, J C Niland, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Journal of Pediatric Surgery|May 1, 1989
Intravenous digital subtraction angiography: its use in evaluating vascular injuries in childrenP M Parker, C D Vinocur, E Smergel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1995
Busulfan/cyclophosphamide as conditioning regimen for allogeneic bone marrow transplantation for myelodysplasiaM R O'Donnell, G D Long, P M Parker, et al.
Journal of Steroid Biochemistry|December 1, 1978
Dehydroisoandrosterone sulfate in peripheral blood of premenopausal, pregnant and postmenopausal women and menL Milewich, C Gomez-Sanchez, J D Madden, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1994
High-dose therapy followed by autologous peripheral-blood stem-cell transplantation for patients with Hodgkin's disease and non-Hodgkin's lymphoma using unprimed and granulocyte colony-stimulating factor-mobilized peripheral-blood stem cellsA Nademanee, I Sniecinski, G M Schmidt, et al.
Blood|March 1, 1995
High-dose chemotherapy with or without total body irradiation followed by autologous bone marrow and/or peripheral blood stem cell transplantation for patients with relapsed and refractory Hodgkin's disease: results in 85 patients with analysis of prognostic factorsA Nademanee, M R O'Donnell, D S Snyder, et al.
Blood|September 1, 1994
Fractionated total-body irradiation and high-dose etoposide as a preparatory regimen for bone marrow transplantation for 94 patients with chronic myelogenous leukemia in chronic phaseD S Snyder, R S Negrin, M R O'Donnell, et al.
Blood|August 1, 1987
Bone marrow transplantation for patients with Philadelphia chromosome-positive acute lymphoblastic leukemiaS J Forman, M R O'Donnell, A P Nademanee, et al.
Blood|October 15, 1991
Allogeneic bone marrow transplantation for high-risk acute lymphoblastic leukemia during first complete remissionN J Chao, S J Forman, G M Schmidt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1987
Bone marrow transplantation for myelodysplastic and myeloproliferative syndromesM R O'Donnell, A P Nademanee, D S Snyder, et al.
The New England Journal of Medicine|October 21, 1993
Cyclosporine, methotrexate, and prednisone compared with cyclosporine and prednisone for prophylaxis of acute graft-versus-host diseaseN J Chao, G M Schmidt, J C Niland, et al.
Pageof 3